Related references
Note: Only part of the references are listed.Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment
Cameron Griffiths et al.
CLINICAL MICROBIOLOGY REVIEWS (2017)
Vaccine development for respiratory syncytial virus
Barney S. Graham
CURRENT OPINION IN VIROLOGY (2017)
Structural analogs of pulmonary surfactant phosphatidylglycerol inhibit toll-like receptor 2 and 4 signaling
Pitchaimani Kandasamy et al.
JOURNAL OF LIPID RESEARCH (2016)
Lung Structure and the Intrinsic Challenges of Gas Exchange
Connie C. W. Hsia et al.
COMPREHENSIVE PHYSIOLOGY (2016)
Phosphatidylinositol inhibits respiratory syncytial virus infection
Mari Numata et al.
JOURNAL OF LIPID RESEARCH (2015)
Nanodiscs as a therapeutic delivery agent: inhibition of respiratory syncytial virus infection in the lung
Mari Numata et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2013)
The TLR4 antagonist Eritoran protects mice from lethal influenza infection
Kari Ann Shirey et al.
NATURE (2013)
Recognition of lipopolysaccharide pattern by TLR4 complexes
Beom Seok Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
Phosphatidylglycerol Suppresses Influenza A Virus Infection
Mari Numata et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
PAMPs and DAMPs: signal 0s that spur autophagy and immunity
Daolin Tang et al.
IMMUNOLOGICAL REVIEWS (2012)
Diverse Functions of Pulmonary Collectins in Host Defense of the Lung
Shigeru Ariki et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
Taro Kawai et al.
IMMUNITY (2011)
Pulmonary Surfactant Phosphatidylglycerol Inhibits Mycoplasma pneumoniae-stimulated Eicosanoid Production from Human and Mouse Macrophages
Pitchaimani Kandasamy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection
Mari Numata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Anionic Pulmonary Surfactant Phospholipids Inhibit Inflammatory Responses from Alveolar Macrophages and U937 Cells by Binding the Lipopolysaccharide-interacting Proteins CD14 and MD-2
Koji Kuronuma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
An overview of pulmonary surfactant in the neonate: Genetics, metabolism, and the role of surfactant in health and disease
Paul O. Nkadi et al.
MOLECULAR GENETICS AND METABOLISM (2009)
Genetic Disorders of Surfactant Dysfunction
Susan E. Wert et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2009)
Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury
Yumiko Imai et al.
CELL (2008)
Immunoregulatory functions of surfactant proteins
JR Wright
NATURE REVIEWS IMMUNOLOGY (2005)
By binding SIRPα or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation
SJ Gardai et al.
CELL (2003)
Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus
LM Haynes et al.
JOURNAL OF VIROLOGY (2001)
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
EA Kurt-Jones et al.
NATURE IMMUNOLOGY (2000)
Role of pulmonary surfactant components in surface film formation and dynamics
EJA Veldhuizen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2000)
Surfactant proteins A and D bind CD14 by different mechanisms
H Sano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
